Ivey Business School (Canada)
-
Change at Pfizer: Jeff Kindler (C) Post Wyeth Acquisition Organization
Michael J. Rouse; Chander SehgalCase IVEY-9B10M054-EStrategyThis case is a supplement to Change at Pfizer: Jeff Kindler (A).Starting at €5.74
-
Strategizing at Monarchia Matt International (MMI)
Michael J. Rouse; Jordan MitchellCase IVEY-9B07M014-EEntrepreneurship, StrategyAs of late 2004, the chief executive officer (CEO) of New York-based wine distributor Monarchia Matt International (MMI) is looking at his portfolio of wines and wondering what advantage Hungarian wine could provide in becoming a powerful niche player in the highly fragmented and complicated U.S. wine industry. The CEO is cognizant of Hungarian wine's reputation in the United States as an inexpensive, mass-quantity produced and low quality drink....Starting at €8.20
-
Netflix Inc.: The Second Act - Moving into Streaming
Sayan Chatterjee; Wayne Barry; Alexander HopkinsCase IVEY-9B16M080-EEntrepreneurship, Marketing, StrategyIn late 2011, Netflix was migrating from its highly successful business model of delivering DVDs by mail to streaming movies and other media content directly to subscribers' televisions. To be profitable, Netflix decided to charge more for receiving DVDs by mail—a service that its existing customers had come to expect as a minor add-on to their original subscription arrangement. This charge led to a huge backlash: subscribers defected and Netflix...Starting at €8.20
-
Netflix Inc.: Proving the Skeptics Wrong
Sayan Chatterjee; Wayne Barry; Alexander HopkinsCase IVEY-9B16M081-EEntrepreneurship, Marketing, StrategyNetflix, a subscription-based movie and television show rental service, offered content to subscribers either via DVDs delivered by mail, or through Internet-based streaming. After splitting the two services, the company lost subscribers, and its stock price plummeted. Most observers were skeptical that Netflix could maintain its profit margins, given the increased cost of acquiring streamable content. However, Netflix not only reduced its cost p...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (A)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M014-EStrategyPfizer Inc., the largest research-based drug company in the world, was faced with multiple challenges, including fierce court battles with generic drug companies over the patents of Lipitor, reduced productivity from research and development, and a changing external health care environment globally, with growing importance of emerging markets. These challenges were set within a business environment characterized by multi-level change and uncertai...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (B) The Wyeth Acquisition
Michael J. Rouse; Chander SehgalCase IVEY-9B10M053-EStrategyThis supplement to Change at Pfizer: Jeff Kindler (A) deals with Pfizer’s 2009 acquisition of Wyeth — the first mega-acquisition since the world economic crisis.Starting at €5.74